Silence Therapeutics plc (SLN)
NASDAQ·Healthcare·Biotechnology
$7.71
-1.41%
Mkt Cap $292.38M
Next Earnings
In 15 daysThu, May 14, 2026
EPS Estimate
-$0.18
1 analysts
Revenue Estimate
$1.25M
Last quarter: beat by +21.88% on EPS, -98.66% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$292.38M
P/E
—
Fwd P/E
—
P/S
650.63
Rev TTM
—
EPS TTM
-$1.88